Clinical Trial Update: FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating fMRI brain activation during aripiprazole treatment in autism spectrum disorder; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism Spectrum Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-03-11